CareLit · DOI-Nachweis · Klinische Pädiatrie
Cancer/Testis Antigen 96 (Dual Specificity Protein Kinase TTK) is an Interesting Target for Hodgkin's Lymphoma
DOI 10.1055/s-0034-1371152
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Kewitz, I Volkmer, MS Staege
ZeitschriftKlinische Pädiatrie
Ausgabe03/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Question: The prognosis of patients with a Hodgkin's lymphoma (HL) has been improved during the last years. But there are still patients which cannot be cured with current therapy regimes. Therefore it is important to identify new therapeutic targets to create new therapy options. Methods: In order to identify genes which might be associated with the resistance of HL cells against cytotoxic drugs we established a cD…
Zitieren
Zitierempfehlung
S Kewitz, I Volkmer, MS Staege (2014) Cancer/Testis Antigen 96 (Dual Specificity Protein Kinase TTK) is an Interesting Target for Hodgkin's Lymphoma. Klinische Pädiatrie (03). https://doi.org/10.1055/s-0034-1371152
Mit CareLit weiterarbeiten